TScan Therapeutics, Inc (TCRX) IPO Opens 20% Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.20 -0.02 (9.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.22 | 52 Week High | $26.80 | |||
| Open | $0.22 | 52 Week Low | $23.00 | |||
| Day High | $0.23 | P/E | N/A | |||
| Day Low | $0.20 | EPS | $0.00 | |||
| Volume | 262,783 | |||||
